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INTRODUCTION:  Occult  endometrial  cancer  after  supracervical  hysterectomy  is  very uncommon.  Even
if  optimal  management  of those  rare  cases  is  still  unproven,  to  guide  the  need for  further  therapies,
restaging  should  be  recommended  in  this  situation.
PRESENTATION OF  CASE:  We  report  of  a 60-year  old  woman  with  occult  high  risk  endometrial  cancer  after
supracervical  hysterectomy  with  morcellation.  We  describe  the  feasibility  of laparoscopic  intraoperative
sentinel  node  identiﬁcation  with  cervical  stump  removing  to  restage  the suspicious  early  stage  high  risk
endometrial  cancer.igh  risk endometrial cancer
upracervical hysterectomy
orcellation
DISCUSSION: In high  risk  endometrial  cancer  surgical  restaging  is important,  considering  that  10–35%  of
cases  can  present  pelvic  nodal  metastasis.  To  reduce  the  treatment  related  morbidity  maintaining  the
beneﬁt  of  surgical  staging,  with  a negative  preoperative  PET/CT,  we  performed  a  laparoscopic  SN  mapping
with  cervical  stump  removing.
CONCLUSION: This  report highlight  the  fact  that SN mapping  with  cervical  injection  is a  feasible  and  safe
technique  also without  the  uterine  corpus  after supracervical  hysterectomy  with  morcellation.
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. Introduction
Despite endometrial cancer represents the most common gyne-
ologic malignancy in the developed countries, with the majority
f women presenting with early stage disease and usually favor-
ble prognosis,1 unexpected endometrial cancer after supracervical
ysterectomy is very uncommon. Usually it occurs in uneval-
ated postmenopausal women operated for suspicious benign
isease and optimal management of these cases is still unproven.
owever, to tailor postoperative therapies, restaging should be rec-
mmended in this situation.
Complete surgical staging in early stage disease is still argu-
ent of debate, with no clear improvement of patients survival. In
rder to reduce the associated morbidity of comprehensive lym-
hadenectomy, without losing important information regarding
he extent of lymphnode involvement, sentinel node (SN) mapping
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appears to be a feasible and reliable treatment option for early-
stage endometrial cancer.
We describe the feasibility of laparoscopic intraoperative sen-
tinel node identiﬁcation with cervical stump removing for the
treatment of occult high risk endometrial cancer after supracervical
hysterectomy with morcellation.
2.  Case report
A  60-year old woman came to our attention after she had
undergone a laparoscopic supracervical hysterectomy due to mul-
tiple uterine myomas with laparoscopic morcellation. Our internal
histopathologic examination demonstrated a poorly differenti-
ated endometrial adenocarcinoma. Deep of myometrial inﬁltration
could not be deﬁned due to the fragmentation of the sample.
Colpocytology and cervical biopsy after hysteroscopic evaluation of
the stump were negative with rare atypical aspects of cells. The 18
F-FDG PET/CT scan was negative for suspicious nodal involvement.
A laparoscopic removing of the cervical stump with intraoperative
sentinel node detection and pelvic lymphadenectomy was consid-
ered, and the patient gave her written consent.
Open access under CC BY-NC-ND license.After the approval of the Internal Review Board for performing
the technique of sentinel node identiﬁcation, the preoperative pro-
tocol of sentinel node in endometrial cancer was  applied as already
described.2
s Ltd. Open access under CC BY-NC-ND license.
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uFig. 1. A left iliac blue sentinel lymphnode.
The day before surgery, 4 submucosal cervical injections of
00–300 mCi  radiolabeled ﬁltered technetium 99 m Tc albumin
anocolloid in 0.2–0.3 mL  volume using 22-gauge spinal needles
ere performed, followed 3 h later by a SPECT/CT study with a
ybrid system composed of a dual-head gamma  camera with a low-
ose X-ray tube installed in a gantry (Inﬁnia Hawkeye 4, GE Medical
ystems). Under general anesthesia just before surgery, the cervix
as injected at 3 and 9-o’clock positions with a total of 2 mL  of
ethylene blue dye (methylene blue 1%, Biondustria L.I.M., Novi
igure, Italy). The abdominal cavity was inspected and pelvic and
bdominal cytological washing were performed. First, the pelvic
nd aortic regions were carefully explored by a laparoscopic 10-
m OmniProbe EL 90-degree detection system (C-Track Galaxy
W4000 System, Southern Scientiﬁc Ltd., UK). Afterwards, peri-
oneum was opened and paravesical and pararectal spaces were
elivered. Two hot and blue sentinel nodes were detected in the
entral aspect of the left external iliac vessels and in the right
uperﬁcial common iliac lymphnode (see Fig. 1). Complete pelvic
ilateral lymphadenectomy was performed and the cervical stump
as ﬁnally removed as in the class A Querleu-Morrow classiﬁcation
ith 0.5–1 cm of vaginal segment. The vaginal cuff was closed vagi-
ally using a running suture with polyglicactin 2-0. The operative
ime was 140 min. No intraoperative or postoperative complica-
ions occurred and the patient was discharged the day after surgery.
The hystopathologic examination showed a 3.5 cm × 1.6 cm cer-
ical surgical specimen negative for residual disease. The two
entinel node were negative for metastasis after hematoxylin and
osin (H&E) staining and cytokeratin immunohistochemical anal-
sis. All pelvic lymphnode (15/15) were negative for metastasis.
eritoneal washing was also negative. At last follow-up visit, one
ear after surgery, the woman  has no evidence of recurrence.
. Discussion
After introduction from Semm of ﬁrst uterine morcellator in
991, laparoscopic supracervical hysterectomy is still performed
or a variety of benign indications including both patients and sur-
eons preferences. The risk of morcellation during laparoscopic
urgery is that small tissue fragments may  be dispersed and remain
nto peritoneal cavity and abdominal wall. This can be detrimen-
al if occult uterine malignancy is discovered. Endometrial cancer
fter supracervical hysterectomy for benign conditions is very
ncommon, and the optimal management of this condition is still
nproven because the small amount of reported experiences in the
iterature.3–5 When surgery is performed by laparoscopy and the
terus is removed from the abdominal cavity with morcellation,PEN  ACCESS
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treatment strategy must take in account some important issues: (1)
the impossibility to determine the deep of myometrial inﬁltration
and risk factors on the surgical specimen, that are directly associ-
ated with the risk of lymphnode metastasis, (2) the true extent of
disease and the regional spread are unknown, and (3) the risk of
dissemination of cancer cells in the abdomen during morcellation.
As stipulated by the American Joint Committee on Cancer (AJCC), all
patients in this clinical situation must be surgically staged in order
to receive appropriate adjuvant treatment.3
However, the appropriate extent of surgical staging in endome-
trial cancer remains controversial due to the negative results of
randomized trials lacking to demonstrated the therapeutic role
of lymphadenectomy in early stage disease. However, in sus-
picious stage I high risk endometrial cancer there is a 10–35%
probability of pelvic nodal metastasis, and many gynaecologic
oncologists still consider mandatory an extensive retroperitoneal
staging.
To reduce the treatment related morbidity, maintaining the ben-
eﬁt of surgical staging, in the last decade the clinical research was
focused on the sentinel node mapping and on the introduction of
innovative and more accurate preoperative imaging as 18F-FDG
PET/CT.
In the concept of detecting lymphnode metastasis to guide
the need for further therapy, SN concept has received increas-
ing attention in endometrial cancer. The SENTI ENDO multicentric
prospective study6 and more recently the study of Khoury-Collado
et al.7,8 demonstrated that applying a SN algorithm approach
in endometrial cancer patients has an high detection rate of
micrometastasis by serial sectioning and immunohistochemical
ultrastaging, which may  otherwise be missed with routine H&E.
18F-FDG PET/CT has proved high performance in the detec-
tion of nodal metastases and recurrent endometrial cancer. In
our prospective study on 37 high risk endometrial cancer, PET/CT
demonstrated a high negative predictive value (NPV) for the preop-
erative evaluation of pelvic node metastasis, with a patient-based
sensitivity of 77.8% and NPV of 97.2%.9
A recent review of the literature conﬁrms the reliability of
a positive PET/CT to detect nodal involvement in patients with
untreated endometrial cancer, helping surgeons in selecting appro-
priate patients on whom perform extensive lymphadenectomy.10
To improve the diagnosis of micro metastases under the PET/CT
spatial resolution of 5 mm,  we introduced in our clinical practise
the SN mapping. Over 60 patients (20 in the high risk group) with
endometrial cancer were surgically treated with SN biopsy and sys-
tematic lymphadenectomy: no false negative cases occurred over
the last two years. Five out of twenty patients in high risk sub-
group (25%) had nodal metastasis, of which two  detected with both
PET/CT and SN and three only by SN. Consequently the introduction
of SN mapping had dramatically implemented the surgical staging
also compared with traditional lymphadenectomy. According to
our results and the emerging literature data, we have just adopted
an innovative algorithm for the treatment of endometrial cancer,
based on the integration of 18F-FDG PET/CT and SN mapping (see
Fig. 2).
To our knowledge, this is the ﬁrst report of SN mapping in a
case of high risk endometrial cancer after laparoscopic supracervi-
cal hysterectomy with morcellation. Similar to our experience, the
report of Diaz-Feijoo et al.,11 recently described a successful case
of radical trachelectomy with SN identiﬁcation in a case of cervical
stump tumor after open subtotal hysterectomy.
In the largest series of Einstein et al., in surgically restaged
uterine cancer after supracervical hysterectomy, 15% of cases (2
patients) were upstaged, and both had a leiomyosarcoma after
laparoscopic uterine morcellation. None of 8/17 women with
endometrial adenocarcinoma were upstaged and/or presented
lymphnode metastasis.3 Notwithstanding, the importance of
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FFig. 2. Flow chart of the diagnostic 18F-FDG PET/CT and senti
ompleting the surgical staging is highlighted in all the reported
xperience.
Because the very low risk of nodal involvement with neg-
tive preoperative 18F-FDG PET/CT, we decided to perform a
aparoscopic SN mapping with cervical stump removal. Pelvic
ymphadenectomy was then performed since the technique
f SN mapping is not yet a gold standard in this set-
ing. The rationale to use the cervix as site of injection for
N mapping is based on the evidence emerging from the
orphological studies. Lymphatic drainage of the cervix and
he corpus of uterus follows a bilateral complex network
f lymphatic channels draining from the lateral parametrial
egion into the external iliac, interiliac and common iliac
odes. Therefore, even in case of altered anatomy by previ-
us surgery, development of retroperitoneal avascular space was
erformed without difﬁculty with intact lymphatic drainage path-
ays.
This report highlights the fact that SN mapping with cervical
njection is a feasible and safe technique also without the uterine
orpus after supracervical hysterectomy with morcellation. More-
ver, laparoscopic approach represents a reasonable technique to
educe and limiting both intraoperative and postoperative compli-
ations in a subset of patients that often have many comorbidities
nd/or are obese.
Our observation reinforce the increasing credibility of SN map-
ing in endometrial cancer. Further studies are awaited to ﬁnd out
eliable SN algorithm in high risk endometrial cancer staging. Fur-
hermore, gynaecologic oncology community must consider the
igh negative predictive value of 18F-FDG PET/CT in this setting,
nd should explore further strategies of selective lymphadenec-
omy incorporating PET/CT and SN mapping, in order to minimize
urgical and postoperative complications and to determine cost-
ffectiveness impact on care of women with high risk endometrial
ancer.
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